Review
Published · Updated · 2 min read
Nilotinib capsules: Ukrainian Ministry of Health order on state registration
What it means for practice
Verify nilotinib registration and dispensing conditions against the full order and approved prescribing information. The available webpage and attached abstract are insufficient grounds for changing treatment.
Summary
What was reported
The website of the State Expert Centre of the Ministry of Health of Ukraine hosts a page for Ministry of Health Order No. 1670 of 28 October 2026, with a link to a DOCX document. According to the abstract attached to the source, the order concerns the state registration of nilotinib capsules, a medicine for cancer treatment.
Content of the registration notice
The abstract describes registration following procurement by authorised health procurement entities. It identifies the manufacturer as MSN Laboratories Private Limited, India, and states that the medicine is available by prescription. According to the abstract, the document provides information on the pharmaceutical form, packaging and registration procedure under Ukrainian medicines legislation.
Limits of the available information
The text of the order and its annexes are absent from the supplied material. Specific capsule strengths, packaging options, approved indications and conditions of use are therefore not reported here. The available material contains no efficacy or safety study results and does not support conclusions about nilotinib’s benefits or a change in its risk profile.
Source
-
Наказ МОЗ України від 28 жовтня 2026 року №1670. Державний експертний центр МОЗ України.
Reviewed by: DrugCard editorial team ·
This article does not replace clinical judgement. Disclaimer
